Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial

Early experience in MS generated concerns that interferon beta treatment might provoke onset or worsening of depression. The objective of the study was to compare depression incidence in relapsing–remitting MS patients receiving interferon beta-1b (IFNB-1b) or glatiramer acetate (GA) in the BEYOND t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schippling, Sven, O’Connor, Paul, Knappertz, Volker, Pohl, Christoph, Bogumil, Timon, Suarez, Gustavo, Cook, Stuart, Filippi, Massimo, Hartung, Hans-Peter, Comi, Giancarlo, Jeffery, Douglas R., Kappos, Ludwig, Goodin, Douglas S., Arnason, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929160/
https://www.ncbi.nlm.nih.gov/pubmed/27177997
http://dx.doi.org/10.1007/s00415-016-8146-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929160/
https://www.ncbi.nlm.nih.gov/pubmed/27177997
http://dx.doi.org/10.1007/s00415-016-8146-8

Ejemplares similares